Basics Insmed, Inc. Insmed Inc is a global biotechnology company. It is focused on developing novel therapies that focus primarily on lung diseases. IPO Date: June 1, 2000 Sector: Healthcare Industry: Biotech Market Cap: $34.86B Activated in VL: True Average Daily Range Avg Daily Range: $0.46 | 2.81% Avg Daily Range (30 D): $2.96 | 1.61% Avg Daily Range (90 D): $2.85 | 1.63% Institutional Daily Volume Avg Daily Volume: .82M Avg Daily Volume (30 D): 2.5M Avg Daily Volume (90 D): 2.01M Trade Size Avg Trade Size (Sh.): 124 Avg Trade Size (Sh.) (30 D): 57 Avg Trade Size (Sh.) (90 D): 52 Institutional Trades Total Inst.Trades: 9,372 Avg Inst. Trade: $4.71M Avg Inst. Trade (30 D): $28.51M Avg Inst. Trade (90 D): $21.78M Avg Inst. Trade Volume: .09M Avg Inst. Trades (Per Day): 3 Market Closing Trades Avg Closing Trade: $10.67M Avg Closing Trade (30 D): $149.65M Avg Closing Trade (90 D): $102.88M Avg Closing Volume: 182.84K     News Jan 6, 2026 @ 10:12 PM Stock Market Today, Jan. 6: Alumis Shares Surge on... Source: Howard Smith Dec 21, 2025 @ 3:01 PM Nike, Insmed, And Arm Are Among Top 10 Large Cap L... Source: Nabaparna Bhattacharya Dec 13, 2025 @ 1:00 AM Annual Changes to the Nasdaq-100 Index® Source: Nasdaq Nov 30, 2025 @ 8:14 AM 30% of Billionaire Stanley Druckenmiller's Portfol... Source: Bram Berkowitz Sep 8, 2025 @ 5:00 PM DPP1 Inhibitor Market Set to Reach New Heights in ... Source: Delveinsight Financials   TTM Q3 2025 Q2 2025 Basic EPS $-6.19 $-1.75 $-1.7 Diluted EPS $-6.19 $-1.75 $-1.7 Revenue $ 447.02M $ 142.34M $ 107.42M Gross Profit $ 342.15M $ 112.98M $ 79.34M Net Income / Loss $ -1183.84M $ -370.02M $ -321.69M Operating Income / Loss $ -1157.44M $ -366.01M $ -312.88M Cost of Revenue $ 104.87M $ 29.37M $ 28.08M Net Cash Flow $ -126.69M $ -949.56M $ 881.08M PE Ratio     Splits Mar 03, 2011:   1:10 Jul 31, 2000:   1:4